Rejected from Molecular Cell? The 7 Best Journals to Submit Next

Molecular Cell sits at a specific intersection: molecular mechanism with biological relevance. The journal wants to know exactly how a molecular process works, and why it matters biologically.

What the editors screen for

Molecular depth. Molecular Cell expects biochemical reconstitution, structural data (cryo-EM, crystallography, NMR), or detailed kinetic analysis. Cell biology experiments alone, even elegant ones, don't meet the bar unless they reveal molecular mechanism.

Mechanistic completeness. Showing that protein X interacts with protein Y isn't enough. Molecular Cell wants to know the binding interface, the structural consequences, the downstream effects on the pathway, and the biological context. Partial mechanisms get desk-rejected.

Biological significance beyond the molecule. The molecular mechanism must illuminate a biological process. A structural study of a protein with no known function, however beautiful, may not satisfy the editors unless the function is revealed alongside the structure.

Common rejection patterns

"The molecular mechanism is not sufficiently characterized." You showed an interaction but didn't explain how it works. Molecular Cell wants binding domains, structural basis, and functional consequences.

"The biological significance is unclear." You solved a structure or characterized a pathway, but the connection to a biological process is weak. Molecular Cell needs both the molecule and the biology.

"The work is primarily cell biology." You used advanced imaging or cell biology techniques to show how a cellular process works, but the molecular mechanism driving the process isn't revealed. Molecular Cell wants the molecular explanation.

1. EMBO Journal

EMBO Journal is the European counterpart to Molecular Cell. Both journals value mechanistic molecular biology with functional insight. The difference is editorial style: Molecular Cell follows the Cell Press comprehensive-story model, while EMBO Journal is sometimes more receptive to focused studies that reveal one clear molecular mechanism.

EMBO Journal's transparent review process (referees see each other's reports) tends to produce balanced, constructive feedback. If your Molecular Cell experience involved an outlier harsh reviewer, EMBO's system mitigates that risk.

Best for: Molecular biology with functional implications, gene regulation, chromatin biology, RNA biology, and protein quality control.

2. NSMB (Nature Structural and Molecular Biology)

If your paper's primary contribution is structural, NSMB is the most natural alternative. The journal publishes cryo-EM structures, crystallography, and integrative structural studies with a focus on biological mechanism. Where Molecular Cell expects the full biological story alongside the structure, NSMB is sometimes more receptive to structures that illuminate mechanism even without complete biological characterization.

Best for: Cryo-EM structures with mechanistic insight, structural biology of macromolecular complexes, structure-function relationships.

3. Cell Reports

Cell Reports is the broad-scope Cell Press journal with a ~25% acceptance rate. For molecular biology papers that Molecular Cell found incomplete or too focused, Cell Reports accepts the work with what you have. The molecular bar is lower, and the biological story doesn't need to be fully connected.

Best for: Molecular biology papers with strong but incomplete mechanisms. Papers where Molecular Cell asked for structural or biochemical data you can't generate.

4. Nucleic Acids Research

For papers focused on DNA biology, RNA biology, gene regulation, or chromatin, NAR is an excellent venue. The journal's scope aligns well with many Molecular Cell submissions, and the acceptance rate (~20%) is more accessible.

NAR also publishes databases, computational tools, and resources for the nucleic acid research community. If your paper includes a new tool or resource alongside the biological finding, NAR values that dual contribution.

Best for: Gene regulation, RNA biology, DNA repair, chromatin biology, transcription mechanisms.

5. eLife

eLife publishes molecular mechanism papers with a commitment to open science and transparent review. The journal's "publish, then curate" model means your paper gets published with reviews attached, letting the community judge the work in context.

For molecular biology papers where the mechanism is strong but the completeness doesn't meet Molecular Cell's standard, eLife's model may work in your favor: the reviews explain what's established and what's still open.

Best for: Molecular mechanism papers with strong but incomplete stories, papers where transparent review benefits the narrative.

6. PNAS

PNAS publishes molecular biology across all areas and values rigor over narrative completeness. A focused biochemical study with clean data can succeed at PNAS even if the full biological story isn't connected. The journal is also strong for structural biology, protein engineering, and molecular evolution.

Best for: Focused molecular mechanism studies, structural biology, protein biochemistry, molecular evolution.

7. Nature Communications

For molecular biology papers that are clearly good science but don't fit the specific editorial mandates of Molecular Cell or NSMB, Nature Communications provides a broad-scope home.

Best for: Solid molecular biology that fell below Molecular Cell's impact or completeness bar.

Structural paper rejected? NSMB first, then NAR (for nucleic acid structures) or PNAS (for protein structures).

Gene regulation paper rejected? EMBO Journal first, then NAR, then PNAS.

Incomplete molecular mechanism? Cell Reports (accepts partial stories) or Nature Communications (broad scope).

Rejected after peer review? Fix reviewer concerns. Then try EMBO Journal or NSMB, whose reviewer pools overlap with Molecular Cell.

Run your manuscript through a free Manusights scan to check scope alignment, formatting, and completeness before your next submission.